Jashin Wu
Dermatology · Corona, CANPI 1407953102
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.6%), grants and consulting fees — rather than concentrated in one kind of arrangement. 46 manufacturers reported payments, led by AbbVie at 33.3% of the total. Reporting peaked in 2019 at $889,500 and has fallen 84.4% since, to $138,681 in 2025. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,654 payments — averaging $1220.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$673K
- Sun Pharmaceutical Industries Inc.$304K
- Amgen$140K
- Bristol Myers Squibb$132K
- Novartis$114K
- Regeneron Healthcare Solutions, Inc.$105K
- plus $552K from 40 others
Across 64 payments — averaging $4529.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$186K
- AbbVie$61K
- Amgen$11K
- Regeneron$11K
- Novartis$9K
- Merck$4K
- plus $8K from 5 others
What the payments were for
- Consulting fees$285,96614%
- Speaking & faculty fees$981,12549%
- Grants$527,80026%
- Travel & lodging$155,1788%
- Food & beverage$55,3883%
- Education$13,6311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$563,407
- ILUMYA$289,874
- Otezla$262,241
- COSENTYX$111,263
- DUPIXENT$103,281
- Rinvoq$57,356
- Humira$45,092
- SILIQ$43,254
- NEMLUVIO$41,461
- ORENCIA$38,441
- Cimzia$36,057
- Klisyri$33,452
- Clarify Medical$27,875
- DUOBRII$20,858
- Tremfya$10,202
- WYNZORA$8,988
- Mind.PX$3,875
- Clarify Home Light Therapy System$3,413
- Winlevi$3,113
- ADBRY$2,896
How this compares
$2,019,088 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 29 | $662 |
| Tacrolimus | 12 | $450 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Corona
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
- Tina BhutaniSan Francisco$1.1M
- Jenny MuraseMountain View$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.